Memory cytotoxic t lymphocyte responses in human immunodeficiency virus type 1 (HIV-1)-negative volunteers immunized with a recombinant canarypox expressing gp160 of HIV-1 and boosted with a recombinant gp160

Journal of Infectious Diseases

Volumn 174, Issue 4, 1996, Pages 734-738

  Fleury, Béatrice ^c   Janvier, Geneviève ^c   Pialoux, Gilles ^c   Buseyne, Florence ^c   Robertson, Michael N ^b   Tartaglia, James ^c   Paoletti, Enzo ^c   Kieny, Marie Paule ^c   Excler, Jean Louis ^c   Rivière, Yves ^a  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; GLYCOPROTEIN GP 160; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; RECOMBINANT PROTEIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; FOWLPOX VIRUS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MALE; MEMORY CELL; MONONUCLEAR CELL; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; TARGET CELL DESTRUCTION; VIRUS RECOMBINANT;

EID: 19244362119     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.4.734     Document Type: Article

References (19)

1. Burke DS. Human trials of experimental HIV vaccines. AIDS 1995; 9(suppl A):S171-80.
2. Dolin R. Human studies in the development of human immunodeficiency virus vaccines. J Infect Dis 1995;172:1175-83.
3. Graham BS, Wright PF. Candidate AIDS vaccines. N Engl J Med 1995; 333:1331-9.
4. Brochier B, Kieny MP, Costy F, et al. Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine. Nature 1991;354:520-2.
5. Fenner F. Poxviruscs. In: Fields BN, Knipe DM, Chanock RM, et al. Fields virology. New York: Raven Press, 1990:2113-33.
6. Taylor J, Weinberg R, Kawaoka Y, Webster RG, Paoletti E. Protective immunity against avian influenza induced by a fowlpox virus recombinant. Vaccine 1988;6:504-6.
7. Wild F, Giraudon P, Spehner D, Drillien R, Lecocq JP. Fowlpox virus recombinant encoding the measles virus fusion protein: protection of mice against fatal measles encephalitis. Vaccine 1990;8:441-2.
8. Pialoux G, Excler JL, Rivière Y, et al. A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). AIDS Res Hum Retroviruses 1995; 11:373-81.
9. MN. J Infect Dis 1994;169: 274-80.
10. McChesney M, Tanneau F, Regnault A, et al. Detection of primary cytotoxic T lymphocytes specific for the envelope glycoprotein of HIV-1 by deletion of the env amino terminal signal sequence. Eur J Immunol 1990;20:215-20.
11. Buseyne F, McChesney M, Porrot F, Kovarik S, Guy B, Rivière Y. Gag specific cytotoxic T lymphocytes from HIV-1 infected individuals: gag epitopes are clustered in three regions of the p24 gag protein. J Virol 1993;67:694-702.
12. Rivière Y, Tanneau-Salvadori F, Regnault A, et al. HIV-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins. J Virol 1989; 63:2270-7.
13. Buseyne F, Blanche S, Schmitt D, Griscelli C, Rivière Y. Detection of HIV-specific mediated cytotoxicity in peripheral blood from infected children. J Immunol 1993;150:3569-81.
14. Matzinger P. Memories are made of this? Nature 1994;369:605-6.
15. Mullbacher A. The long-term maintenance of cytotoxic T cell memory does not require persistence of antigen. J Exp Med 1994;179:317-21.
16. + cell memory. Nature 1994;369:652-4.
17. Lau LL, Jamieson BD, Somasundaram T, Ahmed R. Cytotoxic T cell memory without antigen. Nature 1994;369:648-52.
18. Cooney EL, McElrath MJ, Corey L, et al. Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein. Proc Natl Acad Sci USA 1993;90:1882-6.
19. MN env gene. J Infect Dis 1995;171:1623-7.